Guardant Health, Inc. GH

US Health Care

$158.79 ▲ +5.25% (+$7.92)

Open $152.78

Prev Close $150.87

Day Range $149.40 – $162.96

52W Range $74.55 – $191.05

Market Cap $21.48B

Beta 1.78

EPS (TTM) $-3.50

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-10-04
Shares Out.	134,200,000
Website	guardanthealth.com/ ↗
Phone	13025310855
Employees	2,506
Revenue	$361.0M
Gross Profit	$236.2M
Net Income	-$124.4M
Free Cash Flow	-$232.1M
Total Assets	$1.89B
Total Liabilities	$2.16B
Equity	-$275.9M

About Guardant Health, Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health, Inc. is a publicly traded company under the ticker symbol GH on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.